Between Regional Recommendations and National Implementation: An Analysis of the East African Community Partner States' Legislative Responses to TRIPS Obligations
- PMID: 37215360
- PMCID: PMC10154744
- DOI: 10.1007/s40319-023-01318-7
Between Regional Recommendations and National Implementation: An Analysis of the East African Community Partner States' Legislative Responses to TRIPS Obligations
Abstract
With the access-to-medicines conundrum facing its populations, the East African Community has adopted a policy framework which promotes a collective approach to resolving the access gap in the region. To this end, crucial policy documents on the implementation of TRIPS obligations, harmonisation of drug regulation and boosting regional manufacturing capacity have been adopted. This paper is a case study of the regional policy on the implementation of TRIPS obligations, specifically examining the extent to which partner states' implementation of TRIPS obligations mirrors the regional recommendations. The paper finds that, while many partner states follow the regional recommendations on implementing TRIPS obligations, coherence remains a big challenge. This, the paper concludes, may affect the overall usefulness of a regional approach to solving the access conundrum.
Keywords: Access to medicines; EAC and TRIPS flexibilities; East African Community; Patent laws (Kenya, Uganda, Tanzania, Rwanda, Burundi); TRIPS Agreement.
© Crown 2023.
Similar articles
-
The East African Community (EAC) mobile laboratory networks in Kenya, Burundi, Tanzania, Rwanda, Uganda, and South Sudan-from project implementation to outbreak response against Dengue, Ebola, COVID-19, and epidemic-prone diseases.BMC Med. 2021 Jul 9;19(1):160. doi: 10.1186/s12916-021-02028-y. BMC Med. 2021. PMID: 34238298 Free PMC article.
-
National medicines regulatory authorities financial sustainability in the East African Community.PLoS One. 2020 Jul 23;15(7):e0236332. doi: 10.1371/journal.pone.0236332. eCollection 2020. PLoS One. 2020. PMID: 32702048 Free PMC article.
-
Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.J Pharm Policy Pract. 2018 Dec 4;11:31. doi: 10.1186/s40545-018-0157-7. eCollection 2018. J Pharm Policy Pract. 2018. PMID: 30524732 Free PMC article. Review.
-
Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda.J Pharm Policy Pract. 2023 Jan 30;16(1):18. doi: 10.1186/s40545-022-00497-x. J Pharm Policy Pract. 2023. PMID: 36717871 Free PMC article.
-
What is the impact of intellectual property rules on access to medicines? A systematic review.Global Health. 2022 Apr 15;18(1):40. doi: 10.1186/s12992-022-00826-4. Global Health. 2022. PMID: 35428250 Free PMC article. Review.
References
-
- Abbas M, Riaz S. WTO “Paragraph 6” system for affordable access to medicines: relief or regulatory ritualism? J World Intellect Property. 2017;1:32.
-
- Abbott F. Parallel importation: economic and social welfare dimensions. Winnipeg: International Institute of Sustainable Development; 2007.
-
- Branstetter L. Do stronger patents induce more local innovation? J Int Econ Law. 2004;7(2):359. doi: 10.1093/jiel/7.2.359. - DOI
-
- Carlson D, et al. Patent linchpin for the 21st century? Best mode revisited. IDEA. 2005;45:267.
LinkOut - more resources
Full Text Sources
Miscellaneous